JCRB1801 BALM-25
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1801 | Cell Name | BALM-25 |
---|---|---|---|
Profile | B cell leukemia cell line, ALL-L3 cell line | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 59-year-old |
Identity | not done | Tissue for Primary Cancer | bone marrow |
Case history | Acute lymphoblastic leukemia (ALL) | Metastasis | |
Tissue Metastasized | Genetics | Karyotype information included in established papers | |
Life Span | infinite | Crisis PDL | |
Morphology | lymphoblast-like | Character | Immnoglobulin phenotype and cell surface marker information are included in established paper. |
Classify | tumor | Established by | Matsuo Y |
Registered by | Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Inc | Regulation for Distribution | |
Comment | Year | 2019 | |
Medium | RPMI1640 medium with 10% featal bovine serum. | Methods for Passages | dilution (split ratio 1:2-1:3)/week |
Cell Number on Passage | Race | Japanese | |
CO2 Conc. | 5% | Tissue Sampling | bone marrow |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:15160921 | A novel ALL-L3 cell line, BALM-25, expressing both immunoglobulin light chains. Matsuo Y,Drexler HG,Harashima A,Takenaka K,Ishihara T,Ishimaru F,Orita K Leuk Lymphoma. 2004 Mar;45(3):575-81 |
Images |
---|
LOT Information
Cell No. | JCRB1801 | Cell Name | BALM-25 |
---|---|---|---|
LOT No. | 07052019 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA12J396) | Temperature | 37 C |
Cell Density at Seeding | 4.0-5.0x10^5 cells/ml | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 3.76x10^6 |
Viability at cell freezing (%) | 92.52 | Antibiotics Used | free |
Passage Number | p4* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:12,13 D13S317:11,12 D7S820:8,11 D16S539:9,11 VWA:16 TH01:7 AM:X,Y TPOX:8,12 CSF1PO:10 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | NT | Additional information |
Images |
---|